Skip to content

InsiderTradesSIGMA

RecommendationsTOP BasketNEW TerminalNEW

Companies Executives Performance Blog

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FR US DE CH GB CA IT ES NL BE NO FI DK AU AT IE KR IN JP HK+ 8 markets

Recommendations
Terminal
Companies
Insiders
Performance
Backtest
Compare

Markets
Sectors
Top movers
Leaderboard
Clusters
Heatmap
Archive
Insider buying this week
Cluster signals

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 43 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa, among others. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

Built bySimon Azoulay

All systems operational

InsidersTradesSigma

← Executives ★ Sign in to follow

LW

LINK WILLIAM J PHD

Director

BoardM

USUS·SEC (Form 4)

Oyster Point Pharma, Inc.Oyster Point Pharma, Inc.GLAUKOS Corp RxSight, Inc.Tarsus Pharmaceuticals, Inc.LENSAR, Inc.

Cumul. flow

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€9m

▼ Sales (3 ops.)

Buys 0€8.6M€ Sells

Insider track record

Board Director

Disclosed buys

0

Disclosed sells

3

T+90 hit rate

20%

T+90 mean return

-10.4%

Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Explore the full record of transactions filed by LINK WILLIAM J PHD, Director. Insider active across 6 companies, notably Oyster Point Pharma, Inc.. In total, 41 reports have been recorded. Split: 0 buy · 3 sells. Total volume traded: €8.6m. Activity tracked since 12 May 2021. The latest transaction was filed on 12 August 2024 (J). Regulator: SEC (Form 4). The full history is free.

Declarations41 total

●

LINK WILLIAM J PHD

Director·Executives·12 Aug 2024·Tarsus Pharmaceuticals, Inc.

74,892 shares0Common StockSEC:0000950170-24-097097:0

◇

LINK WILLIAM J PHD

Director·Executives·24 Jun 2024·Tarsus Pharmaceuticals, Inc.

3,350 sharesCommon StockSEC:0001819790-24-000102:0

◆

LINK WILLIAM J PHD

Director·Executives·6 Jun 2024·RxSight, Inc.

2,554 sharesCommon StockSEC:0000950170-24-071313:0

◆

LINK WILLIAM J PHD

Director·Executives·7 May 2024·LENSAR, Inc.

22,000 shares0Common StockSEC:0000950170-24-057102:0

▼

LINK WILLIAM J PHD

Director·Executives·1 Feb 2024·RxSight, Inc.

20,598 shares@ US$49.5415100.0% of flowCommon StockSEC:0000950170-24-010569:0

●

LINK WILLIAM J PHD

Director·Executives·17 Aug 2023·RxSight, Inc.

694,124 shares0Common StockSEC:0001209191-23-046645:0

◇

LINK WILLIAM J PHD

Director·Executives·16 Jun 2023·Tarsus Pharmaceuticals, Inc.

2,000 sharesCommon StockSEC:0001819790-23-000041:0

◆

LINK WILLIAM J PHD

Director·Executives·1 Jun 2023·RxSight, Inc.

5,731 shares0Common StockSEC:0001209191-23-034325:0

◆

LINK WILLIAM J PHD

Director·Executives·25 May 2023·LENSAR, Inc.

9,288 shares0Common StockSEC:0000899243-23-014076:0

●

LINK WILLIAM J PHD

Director·Executives·11 May 2023·Tarsus Pharmaceuticals, Inc.

215,576 shares0Common StockSEC:0001209191-23-029596:0

●

LINK WILLIAM J PHD

Director·Executives·11 May 2023·RxSight, Inc.

258,390 shares0Common StockSEC:0001209191-23-028948:0

●

LINK WILLIAM J PHD

Director·Executives·15 Mar 2023·Tarsus Pharmaceuticals, Inc.

215,575 shares0Common StockSEC:0001209191-23-019891:0

●

LINK WILLIAM J PHD

Director·Executives·9 Nov 2022·RxSight, Inc.

316,694 shares0Common StockSEC:0001209191-22-056565:0

●

LINK WILLIAM J PHD

Director·Executives·10 Nov 2022·Tarsus Pharmaceuticals, Inc.

215,575 shares0Common StockSEC:0001209191-22-056627:0

●

LINK WILLIAM J PHD

Director·Executives·15 Aug 2022·Tarsus Pharmaceuticals, Inc.

215,575 shares0Common StockSEC:0001209191-22-046254:0

●

LINK WILLIAM J PHD

Director·Executives·10 Aug 2022·RxSight, Inc.

316,694 shares0Common StockSEC:0001209191-22-045434:0

●

LINK WILLIAM J PHD

Director·Executives·8 Jun 2022·RxSight, Inc.

375,000 shares0Common StockSEC:0001209191-22-035584:0

●

LINK WILLIAM J PHD

Director·Executives·17 May 2022·RxSight, Inc.

126,979 shares0Common StockSEC:0001209191-22-035013:0

●

LINK WILLIAM J PHD

Director·Executives·15 Mar 2022·RxSight, Inc.

126,979 shares0Common StockSEC:0001209191-22-034997:0

◆

LINK WILLIAM J PHD

Director·Executives·2 Jun 2022·RxSight, Inc.

10,349 shares0Common StockSEC:0001209191-22-034391:0

◆

LINK WILLIAM J PHD

Director·Executives·25 May 2022·LENSAR, Inc.

4,285 shares0Common StockSEC:0000899243-22-020097:0

●

LINK WILLIAM J PHD

Director·Executives·17 May 2022·RxSight, Inc.

375,000 shares0Common StockSEC:0000899243-22-018791:0

●

LINK WILLIAM J PHD

Director·Executives·15 Mar 2022·RxSight, Inc.

375,000 shares0Common StockSEC:0000899243-22-011520:0

●

LINK WILLIAM J PHD

Director·Executives·5 Jan 2022·Oyster Point Pharma, Inc.

6,438 shares0Common StockSEC:0001209191-22-002535

●

LINK WILLIAM J PHD

Director·Executives·5 Jan 2022·Oyster Point Pharma, Inc.

6,438 shares0Common StockSEC:0001209191-22-002535:0

25 of 41 declarations

About LINK WILLIAM J PHD

William J Link, PhD is an executive at Oyster Point Pharma, Inc.

Similar companies

Tarsus Pharmaceuticals, Inc.

Healthcare & Pharma

Healthcare & Pharma

Oyster Point Pharma, Inc.

Healthcare & Pharma

Oyster Point Pharma, Inc.

Healthcare & Pharma

Healthcare & Pharma

Related executives

ATIEH MICHAEL G

Eliades George Christopher

Burns Thomas William

Directeur Général